Advanced search

Combined treatment with the LHRH-agonist buserelin (LHRH-A) and tamoxifen (TAM) vs single treatment with each drug alone in premenopausal metastatic breast cancer. Final results of EORTC study 10881

(1998) ANNALS OF ONCOLOGY. 9. p.11-11
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
KLIJN, JGM, L BEEX, L MAURIAC, J VAN ZIJL, C VEYRET, J WILDIERS, J JASSEM, et al. 1998. “Combined Treatment with the LHRH-agonist Buserelin (LHRH-A) and Tamoxifen (TAM) Vs Single Treatment with Each Drug Alone in Premenopausal Metastatic Breast Cancer. Final Results of EORTC Study 10881.” In Annals of Oncology, 9:11–11. KLUWER ACADEMIC PUBL.
APA
KLIJN, J., BEEX, L., MAURIAC, L., VAN ZIJL, J., VEYRET, C., WILDIERS, J., JASSEM, J., et al. (1998). Combined treatment with the LHRH-agonist buserelin (LHRH-A) and tamoxifen (TAM) vs single treatment with each drug alone in premenopausal metastatic breast cancer. Final results of EORTC study 10881. ANNALS OF ONCOLOGY (Vol. 9, pp. 11–11). KLUWER ACADEMIC PUBL.
Vancouver
1.
KLIJN J, BEEX L, MAURIAC L, VAN ZIJL J, VEYRET C, WILDIERS J, et al. Combined treatment with the LHRH-agonist buserelin (LHRH-A) and tamoxifen (TAM) vs single treatment with each drug alone in premenopausal metastatic breast cancer. Final results of EORTC study 10881. ANNALS OF ONCOLOGY. KLUWER ACADEMIC PUBL; 1998. p. 11–11.
MLA
KLIJN, JGM, L BEEX, L MAURIAC, et al. “Combined Treatment with the LHRH-agonist Buserelin (LHRH-A) and Tamoxifen (TAM) Vs Single Treatment with Each Drug Alone in Premenopausal Metastatic Breast Cancer. Final Results of EORTC Study 10881.” Annals of Oncology. Vol. 9. KLUWER ACADEMIC PUBL, 1998. 11–11. Print.
@inproceedings{346953,
  author       = {KLIJN, JGM and BEEX, L and MAURIAC, L and VAN ZIJL, J and VEYRET, C and WILDIERS, J and JASSEM, J and BURGHOUTS, J and PICCART, M and MIGNOLET, F and Duchateau, Luc},
  booktitle    = {ANNALS OF ONCOLOGY},
  issn         = {0923-7534},
  language     = {eng},
  pages        = {11--11},
  publisher    = {KLUWER ACADEMIC PUBL},
  title        = {Combined treatment with the LHRH-agonist buserelin (LHRH-A) and tamoxifen (TAM) vs single treatment with each drug alone in premenopausal metastatic breast cancer. Final results of EORTC study 10881},
  volume       = {9},
  year         = {1998},
}

Web of Science
Times cited: